Gazelle Therapeutics® seeks to bring new treatments to patients who have rare diseases, using agility, speed and majesty

There are numerous unmet medical needs for many types of diseases. We are particularly interested in developing novel treatments for rare diseases. Many molecules are only partially progressed through the development cycle. The reasons vary for this, but we want to come alongside pharma companies and develop some of those molecules. We will take them all the way to registration and marketing, in collaboration with the pharma originator. Gazelle Therapeutics® will focus on a rare disease that is driven by the molecule that will be licensed-into the company. To find out more about the types of molecules we are seeking, email Dr. Lorna Speid at LSPEID@SNDTM.COM. We have funding lined up.